GWAS |
- Age at voice drop ( 27182965)
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Chronic obstructive pulmonary disease ( 30804561)
- Depression ( 29700475)
- Leisure-time exercise behaviour ( 30102679)
- Leisure-time exercise behaviour (age-stratified) ( 30102679)
- Lung function (FEV1/FVC) ( 30061609)
- Menarche (age at onset) ( 21102462 25231870)
- Response to statin therapy ( 20339536)
|
- Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) ( 24025145)
- Amyotrophic lateral sclerosis (sporadic) ( 24529757)
- Asthma (childhood onset) ( 27611488)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Lead levels ( 26025379)
- Lung function (FEV1) ( 30061609)
- Lung function (FVC) ( 30061609)
- Monobrow ( 27182965)
- Neuritic plaque ( 31497858)
- Nose size ( 27182965)
- Parkinson's disease ( 26227905)
- Superior frontal gyrus grey matter volume ( 25335168)
- Systolic blood pressure ( 26969751)
|